BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8946091)

  • 1. Urinary retention with fluoxetine-haloperidol combination in a young patient.
    Benazzi F
    Can J Psychiatry; 1996 Nov; 41(9):606-7. PubMed ID: 8946091
    [No Abstract]   [Full Text] [Related]  

  • 2. Urinary retention with venlafaxine-haloperidol combination.
    Benazzi F
    Pharmacopsychiatry; 1997 Jan; 30(1):27. PubMed ID: 9065967
    [No Abstract]   [Full Text] [Related]  

  • 3. Urinary retention caused after fluoxetine-risperidone combination.
    Bozikas V; Petrikis P; Karavatos A
    J Psychopharmacol; 2001 Jun; 15(2):142-3. PubMed ID: 11448089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactation associated with fluoxetine treatment.
    Arya DK; Taylor WS
    Aust N Z J Psychiatry; 1995 Dec; 29(4):697. PubMed ID: 8825840
    [No Abstract]   [Full Text] [Related]  

  • 5. Pilot study of haloperidol, fluoxetine, and placebo for agitation in Alzheimer's disease.
    Auchus AP; Bissey-Black C
    J Neuropsychiatry Clin Neurosci; 1997; 9(4):591-3. PubMed ID: 9447502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible adverse drug interactions between fluoxetine and other psychotropics.
    Lock JD; Gwirtsman HE; Targ EF
    J Clin Psychopharmacol; 1990 Oct; 10(5):383-4. PubMed ID: 2258459
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe anticholinergic side effects with venlafaxine-fluoxetine combination.
    Benazzi F
    Can J Psychiatry; 1997 Nov; 42(9):980-1. PubMed ID: 9429070
    [No Abstract]   [Full Text] [Related]  

  • 8. Urinary retention with reboxetine-fluoxetine combination in a young man.
    Benazzi F
    Can J Psychiatry; 2000 Dec; 45(10):936. PubMed ID: 11190365
    [No Abstract]   [Full Text] [Related]  

  • 9. A toxic reaction from combining fluoxetine and phentermine.
    Bostwick JM; Brown TM
    J Clin Psychopharmacol; 1996 Apr; 16(2):189-90. PubMed ID: 8690835
    [No Abstract]   [Full Text] [Related]  

  • 10. Severe urinary retention requiring urinary catheterization associated with combined treatment of depression with duloxetine and quetiapine.
    Wang SM; Lee KU; Jeon YW; Park EJ; Han SI
    Psychiatry Clin Neurosci; 2013 Apr; 67(3):191. PubMed ID: 23581874
    [No Abstract]   [Full Text] [Related]  

  • 11. Fluoxetine and concomitant centrally acting medication use during clinical trials of depression: the absence of an effect related to agitation and suicidal behavior.
    Wernicke JF; Sayler ME; Koke SC; Pearson DK; Tollefson GD
    Depress Anxiety; 1997; 6(1):31-9. PubMed ID: 9394873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extrapyramidal reactions from concurrent SSRI and atypical antipsychotic use.
    Caley CF
    Can J Psychiatry; 1998 Apr; 43(3):307-8. PubMed ID: 9561323
    [No Abstract]   [Full Text] [Related]  

  • 13. Urinary retention with sertraline, haloperidol, and clonazepam combination.
    Benazzi F
    Can J Psychiatry; 1998 Dec; 43(10):1051-2. PubMed ID: 9868574
    [No Abstract]   [Full Text] [Related]  

  • 14. Fluoxetine and visual hallucinations in dementia.
    Omar SJ; Robinson D; Davies HD; Miller TP; Tinklenberg JR
    Biol Psychiatry; 1995 Oct; 38(8):556-8. PubMed ID: 8562668
    [No Abstract]   [Full Text] [Related]  

  • 15. Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients.
    Diaz A; Fouilloux C; Ortiz S
    Proc West Pharmacol Soc; 2002; 45():154-5. PubMed ID: 12434564
    [No Abstract]   [Full Text] [Related]  

  • 16. Fluoxetine-Induced Acute Urinary Retention in a Child With Depression.
    Haridas NJ; Balan S; Ravindren RK
    Prim Care Companion CNS Disord; 2023 Jun; 25(3):. PubMed ID: 37347673
    [No Abstract]   [Full Text] [Related]  

  • 17. Melancholic symptoms during concurrent olanzapine and fluoxetine.
    Nelson LA; Swartz CM
    Ann Clin Psychiatry; 2000 Sep; 12(3):167-70. PubMed ID: 10984007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Toxic tricyclic drug plasma level caused by fluoxetine].
    Hambrecht M
    Psychiatr Prax; 1995 Nov; 22(6):252-3. PubMed ID: 8570758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Severe Raynaud's phenomenon associated with interferon-beta 1a and fluoxetine].
    De Broucker T; Lhote F
    Ann Med Interne (Paris); 2000 Sep; 151(5):424-5. PubMed ID: 11033481
    [No Abstract]   [Full Text] [Related]  

  • 20. A Case of Caffeine Intolerance With Long-Term Use of Fluoxetine.
    Jamal F; Durgam A; Aickareth G; Bajaj R; Mathews M
    Prim Care Companion CNS Disord; 2017 Jun; 19(3):. PubMed ID: 28590600
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.